miRNA Infomation | |
---|---|
miRNA name | hsa-miR-3676-3p |
Gene Information | |
---|---|
Gene Symbol | PGD |
Synonyms | 6PGD |
Description | phosphogluconate dehydrogenase |
Transcript | NM_002631 |
Expression | |
Putative miRNA Targets on PGD | |
3'UTR of PGD (miRNA target sites are highlighted) |
>PGD|NM_002631|3'UTR 1 TCATGCTGCTCCTGTCACCCTCCACGATTCCACAGACCAGGACATTCCATGTGCCTCATGGCACTGCCACCTGGCCCTTT 81 GCCCTATTTTCTGTTCAGTTTTTTAAAAGTGTTGTAAGAGACTCCTGAGGAAGACACACAGTTTATTTGTAAAGTAGCTC 161 TGTGAGAGCCACCATGCCCTCTGCCCTTGCCTCTTGGGACTGACCAGGAGCTGCTCATGTGCGTGAGAGTGGGAACCATC 241 TCCTTGCGGCAGTGGCTTCCGCGTGCCCCGTGTGCTGGTGCGGTTCCCATCACGCAGACAGGAAGGGTGTTTGCGCACTC 321 TGATCAACTGGAACCTCTGTATCATGCGGCTGAATTCCCTTTTTCCTTTACTCAATAAAAGCTACATCAGACTGATGCTC 401 TTTCTCCAGATTCTTAGTCTCACCTCGGCCACATGGAGCCATTATCCCCATTGGCAGAAAGATTTTTCTTTAAAAAAAAA 481 GACTAGAATAACACAAGAAACCACATTTAGGATTATGCTTCACTCAGAGGAGGCAGGCAGGGAGGACACACCAGGGGCTT 561 TAATACACTGGGCATGTTTTCTTTCTCCAATTGGGCAATGGGTACATGGACGTTCACTGTAACGTGCTTTTTCTTTCGTC 641 TTTTTTTTTTTTTTTTTTTTTTTTGCTCCTGGCAAGCTGTGCGTGACATTCTTTATGGCTTTTTGTATGTCAAATACTTC 721 ATACTAAACTTTCTAGAGAATTAAACTTTAATGATGGGCTCAAAAAAAAAAAAAA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
DRVs in gene 3'UTRs | |
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|
miRNA:Target | ---- | |||||||||
Validation Method |
|
|||||||||
Conditions | Flp-In T-REx 293-hAGO1 cells | |||||||||
Location of target site | CDS | |||||||||
Original Description (Extracted from the article) |
...
Validation of interactions identified by CLASH suppports their reliability.
... - Helwak A; Kudla G; Dudnakova T; Tollervey D, 2013, Cell. |
|||||||||
miRNA-target interactions (Provided by authors) |
|
|||||||||
Article |
- Helwak A; Kudla G; Dudnakova T; Tollervey D - Cell, 2013
MicroRNAs (miRNAs) play key roles in gene regulation, but reliable bioinformatic or experimental identification of their targets remains difficult. To provide an unbiased view of human miRNA targets, we developed a technique for ligation and sequencing of miRNA-target RNA duplexes associated with human AGO1. Here, we report data sets of more than 18,000 high-confidence miRNA-mRNA interactions. The binding of most miRNAs includes the 5' seed region, but around 60% of seed interactions are noncanonical, containing bulged or mismatched nucleotides. Moreover, seed interactions are generally accompanied by specific, nonseed base pairing. 18% of miRNA-mRNA interactions involve the miRNA 3' end, with little evidence for 5' contacts, and some of these were functionally validated. Analyses of miRNA:mRNA base pairing showed that miRNA species systematically differ in their target RNA interactions, and strongly overrepresented motifs were found in the interaction sites of several miRNAs. We speculate that these affect the response of RISC to miRNA-target binding.
LinkOut: [PMID: 23622248]
|
MiRNA-Target Expression Profile | |||||||
---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | |||||||
---|---|---|---|---|---|---|---|
|
6 hsa-miR-3676-3p Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT052869 | PIAS4 | protein inhibitor of activated STAT 4 | 1 | 1 | ||||||||
MIRT052870 | DAG1 | dystroglycan 1 | 1 | 1 | ||||||||
MIRT052871 | DYNC1LI2 | dynein cytoplasmic 1 light intermediate chain 2 | 1 | 1 | ||||||||
MIRT052872 | USP7 | ubiquitin specific peptidase 7 | 1 | 1 | ||||||||
MIRT052873 | PGD | phosphogluconate dehydrogenase | 1 | 1 | ||||||||
MIRT052874 | CTC1 | CST telomere replication complex component 1 | 1 | 1 |
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|